• Alopecia
• Acniform eruptions
• Benign tumors
• Bullous diseases
• Dermoscopy
• Nevi, melanoma
• Nonmelanoma cancer
• Psoriasis and others
• Stds
• Vascular tumors
• Vulvar disease

• Herpes simplex
• Genital Herpes Simplex Introduction STD
• Genital Herpes Simplex Risk factors and Rate of Transmission
• Previous HSV type 1 infection
• Genital Herpes Simplex Primary and Recurrent Infections
• Genital Herpes Simplex Signs and Symptoms
• Genital Herpes Simplex Latency and Reactivation STD
• Genital Herpes Simplex Recurrent Infection STD
• Genital Herpes Simplex Frequency of Recurrence
• Genital Herpes Simplex Anatomic Site
• Genital Herpes Simplex Asymptomatic transmission
• Genital Herpes Simplex Prevention
• Genital Herpes Simplex Laboratory diagnosis
• Genital Herpes Simplex Serology
• Genital Herpes Simplex Testing Pregnant Women
• Genital Herpes Simplex Monogamous Couples
• Genital Herpes Simplex STD Treatment
• Genital Herpes Simplex Daily Treatment Suppressive Therapy
• Genital Herpes Simplex During Pregnancy
• Warts (HPV infection)
• Genital Warts HPV Introduction and Causes STD
• Genital Warts HPV Screening Tests
• Genital Warts HPV Interpretation of Test Results
• Genital Warts HPV The HPV DNA Test
• Genital Warts HPV Lesion and Location
• Genital Warts HPV Lesion Types STD
• Genital Warts HPV Subclinical Lesions
• Genital Warts HPV Bowenoid Papulosis STD
• Genital Warts HPV Clinical Evaluation STD
• Genital Warts HPV Differential diagnosis
• Genital Warts HPV Treatment STD
• Genital Warts HPV Treatment Approach to Therapy
• Molluscum Contagiosum
• Molluscum Contagiosum STD Introduction
• Molluscum Contagiosum Clinical manifestations
• Molluscum Contagiosum Diagnosis
• Molluscum Contagiosum Treatment
• Syphilis
• Syphilis Epidemiology STD
• Syphilis Treponema Pallidum
• Syphilis Causes STD
• Incubating Syphilis
• Secondary Syphilis STD
• Syphilis Latency
• Congenital Syphilis
• Early Congenital Syphilis
• Late Congenital Syphilis
• Syphilis Laboratory Diagnosis
• Syphilis Serologic Tests
• Syphilis Nontreponemal Reaginic Tests
• Syphilis Specific Treponemal Tests
• False-Positive Serologic Test for Syphilis
• Syphilis Treatment STD
• Chancroid
• Chancroid STD Introduction
• Chancroid Clinical presentation
• Chancroid Diagnosis
• Chancroid Treatment STD
• Chancroid Syndromic management
• Lymphogranuloma venereum
• Lymphogranuloma Venereum STD Introduction
• Lymphogranuloma Venereum Clinical features
• Lymphogranuloma Venereum Laboratory diagnosis
• Lymphogranuloma Venereum Treatment
• Donovanosis (granuloma inguinale)
• Donovanosis Granuloma Inguinale STD Introduction
• Donovanosis Granuloma Inguinale STD Clinical apperances
• Donovanosis Granuloma Inguinale STD Diagnostic tests
• Donovanosis Granuloma Inguinale STD Treatment

Chancroid Treatment STD

Treatment

The World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), and the United Kingdom's Clinical Effectiveness Group recommends several different antibiotic regimens. Comparable cure rates for both single dose ciprofloxacin (500 mg) and a 1 week course of erythromycin (500 mg three times daily for seven days) have been demonstrated. Pregnant women should be treated with either erythromycin or ceftriaxone (250 mg, single dose, IM). Patients with HIV infection should be followed because reduced healing of genital ulcers and persistence of H ducreyi in the lesions has been reported. There is also an increased likelihood of treatment failure in uncircumcised individuals with chancroid. Undiagnosed co-existing HSV infection, particularly in immunosuppressed HIV seropositive patients, may account for some of the observed cases where treatment has failed to cure chancroid.

Based on the emergence of resistant strains in Rwanda, the WHO has recommended that chancroid is not treated with trimethoprim/sulfamethoxazole based regimens unless the antimicrobial susceptibility profiles of local H ducreyi isolates are known.

Fluctuant buboes are aspirated to provide symptomatic relief and to avoid spontaneous rupture. Incision and drainage of fluctuant buboes, with subsequent packing of the wound, has also been recommended as an effective management strategy for chancroid and avoids the need for frequent bubo re-aspirations.

Serological screening for both syphilis and HIV infection should be offered at the time of genital ulcer presentation and again after 3 months at the end of the window period for both diseases.